| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |